Area Assessment of Psoriasis Lesion for PASI Scoring

Ihtatho, Dani; Fadzil, M. H. Ahmad; Affandi, Azura Mohd; Hussein, Suraiya H.

doi:10.1109/iembs.2007.4353072

Cited by 19 publications

(21 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Fvirthermore, only 4 out of the 23 studies reviewed used clinical measures such as PASI and PDI. It has been shown that PASI is one of the most important clinical tools available for objectively assessing the magnitude of beneflt resulting from a psoriasis treatment (62). Future studies should therefore employ clinical measures, since dermatologists emphasize the importance of clinically observable criteria (e.g.…”

Section: Discussionmentioning

confidence: 98%

Elicitation and Use of Patients’ Preferences in the Treatment of Psoriasis: A Systematic Review

Umar¹,

Yamamoto²,

Loerbroks³

et al. 2012

Acta Derm Venerol

View full text Add to dashboard Cite

There is a growing advocacy to incorporate patients' preferences in psoriasis treatment. The aim of this study was to critically review the scientific evidence regarding the elicitation and use of patients' preferences in psoriasis treatment. Published studies were systematically identified through PubMed, the Cochrane Library, the Web of Knowledge, and PsychINFO. Additional studies were identified by reviewing the reference lists of retrieved articles and through contact with experts in the field. Included studies involved the elicitation or use of patient preferences related to the treatment of psoriasis or psoriatic arthritis. Twenty-three studies were included in the review. The earliest articles were published in the 1980s. Patients' preferences were elicited for psoriasis treatment options, treatment attributes and for health state characteristics. Preferences were elicited from both patients and physicians. No study examined the use of patients' preferences in psoriasis treatment decision-making. The evidence demonstrates that patients' preferences relevant to psoriasis treatment are present and measurable. How-ever, the potential use of those preferences has largely been ignored.

show abstract

Section: Discussionmentioning

confidence: 98%

Elicitation and Use of Patients’ Preferences in the Treatment of Psoriasis: A Systematic Review

Umar¹,

Yamamoto²,

Loerbroks³

et al. 2012

Acta Derm Venerol

View full text Add to dashboard Cite

show abstract

“…The dependent variables were assessed t 1 , t 2 (twelve weeks post-t 1 ) and t 3 (twelve weeks post-t 2 ). Twelve weeks are known to be sufficient to judge the short-term effectiveness of a psoriasis treatment, but we specifically wanted to look at longer-term outcomes at 24 weeks which may better represent sustainable treatment adherence [17]. Our analyses therefore focused on changes observed between t 1 and t 3 , although additional analyses (not described here) were also performed for changes observed between t 1 and t 2 .…”

Section: Methodsmentioning

confidence: 99%

“…The PASI is a psychometrically valid and reliable instrument routinely applied in dermatology to assess psoriasis severity and gauge treatment effects [17]. PASI combines assessment of the severity of psoriasis lesions and the area affected into a score ranging from 0 (no disease) to 72 (maximal disease), with scores ≥ 10 reflecting moderate to severe disease [17]. …”

Section: Methodsmentioning

confidence: 99%

Outcomes associated with matching patients' treatment preferences to physicians' recommendations: study methodology

Umar

Litaker

Schaarschmidt

et al. 2012

BMC Health Serv Res

285

312

View full text Add to dashboard Cite

BackgroundPatients often express strong preferences for the forms of treatment available for their disease. Incorporating these preferences into the process of treatment decision-making might improve patients' adherence to treatment, contributing to better outcomes. We describe the methodology used in a study aiming to assess treatment outcomes when patients' preferences for treatment are closely matched to recommended treatments.MethodParticipants included patients with moderate and severe psoriasis attending outpatient dermatology clinics at the University Medical Centre Mannheim, University of Heidelberg, Germany. A self-administered online survey used conjoint analysis to measure participants' preferences for psoriasis treatment options at the initial study visit. Physicians' treatment recommendations were abstracted from each participant's medical records. The Preference Matching Index (PMI), a measure of concordance between the participant's preferences for treatment and the physician's recommended treatment, was determined for each participant at t1 (initial study visit). A clinical outcome measure, the Psoriasis Area and Severity Index, and two participant-derived outcomes assessing treatment satisfaction and health related quality of life were employed at t1, t2 (twelve weeks post-t1) and t3 (twelve weeks post-t2). Change in outcomes was assessed using repeated measures analysis of variance. The association between participants' PMI scores at t1 and outcomes at t2 and t3 was evaluated using multivariate regressions analysis.DiscussionWe describe methods for capturing concordance between patients' treatment preferences and recommended treatment and for assessing its association with specific treatment outcomes. The methods are intended to promote the incorporation of patients' preferences in treatment decision-making, enhance treatment satisfaction, and improve treatment effectiveness through greater adherence.

show abstract

“…The dermatologist examined the child, confirmed the psoriasis diagnosis, and classified the psoriasis (guttate, plaque, inverse, erythrodermic, pustular, psoriasis with arthritis). The dermatology research nurse assessed the psoriasis with the Psoriasis Area and Severity Index (PASI) (13).This is the current gold standard method for scoring the severity of psoriasis, by estimating the area, erythema, scaling, and thickness (14). Prior to the study, the dermatologists and the dermatology research nurse had trained in and agreed on how to perform the scoring.…”

Section: History and Examinationmentioning

confidence: 99%

Quality of Life and Clinical Features in Swedish Children with Psoriasis

Gånemo

Wahlgren

Svensson

2011

Pediatric Dermatology

View full text Add to dashboard Cite

Psoriasis is a common, chronic disease and in one-third of the patients it begins during the first 2 decades of life. The burdens of psoriasis are many, and some can be assessed with quality of life questionnaires. The aim was to investigate the impact of childhood psoriasis on quality of life in children and their parents and to correlate certain clinical findings with quality of life. Forty-five Swedish children (4-16 years, 28 girls) with psoriasis, and their parents, were investigated with the validated questionnaires Children's Dermatology Life Quality Index (5-16 years, n = 42), The Infant's Dermatitis Quality of Life Index (4 years, n = 3), and Dermatitis Family Impact (n = 45), the two latter with the word eczema replaced by psoriasis. Clinical examination was performed, and psoriasis severity was scored with Psoriasis Area and Severity Index. Chronic plaque psoriasis was the most common clinical type (87%). Four of the children had joint complaints. Ninety-three percent had pruritus the preceding 3 days. Ninety-three percent were receiving treatment. Median Psoriasis Area and Severity Index score was 3.3 (range 0.5-12.3). Median score for the Infant's Dermatitis Quality of Life Index was 4.0 (range 2-12), for Children's Dermatology Life Quality Index 4.0 (0-24), and for Dermatitis Family Impact questionnaire 4.0 (0-25). No significant gender difference existed. The Children's Dermatology Life Quality Index scores were higher for younger (5-8 yrs) than older (9-16 yrs) children and higher for those with joint complaints. The Dermatitis family impact scores correlated significantly with Children's Dermatology Life Quality Index and Psoriasis Area and Severity Index scores, but the Children's Dermatology Life Quality Index did not correlate with Psoriasis Area and Severity Index. The Visual Analog Scale and quality of life scores were significantly correlated. Psoriasis in children affects quality of life in the subjects and their parents. Joint complaints and pruritus significantly impair quality of life.

show abstract

Area Assessment of Psoriasis Lesion for PASI Scoring

Cited by 19 publications

References 14 publications

Elicitation and Use of Patients’ Preferences in the Treatment of Psoriasis: A Systematic Review

Elicitation and Use of Patients’ Preferences in the Treatment of Psoriasis: A Systematic Review

Outcomes associated with matching patients' treatment preferences to physicians' recommendations: study methodology

Quality of Life and Clinical Features in Swedish Children with Psoriasis

Contact Info

Product

Resources

About